PT1259261E - Composicoes farmaceuticas que compreendem terbinafina - Google Patents

Composicoes farmaceuticas que compreendem terbinafina

Info

Publication number
PT1259261E
PT1259261E PT01902337T PT01902337T PT1259261E PT 1259261 E PT1259261 E PT 1259261E PT 01902337 T PT01902337 T PT 01902337T PT 01902337 T PT01902337 T PT 01902337T PT 1259261 E PT1259261 E PT 1259261E
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
terbinafin
understand
compositions
terbinafine
Prior art date
Application number
PT01902337T
Other languages
English (en)
Portuguese (pt)
Inventor
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Becker Dieter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1259261E publication Critical patent/PT1259261E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01902337T 2000-01-20 2001-01-18 Composicoes farmaceuticas que compreendem terbinafina PT1259261E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds

Publications (1)

Publication Number Publication Date
PT1259261E true PT1259261E (pt) 2005-10-31

Family

ID=9884039

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01902337T PT1259261E (pt) 2000-01-20 2001-01-18 Composicoes farmaceuticas que compreendem terbinafina

Country Status (10)

Country Link
US (2) US20030017200A1 (enExample)
EP (1) EP1259261B1 (enExample)
JP (1) JP2003520252A (enExample)
AT (1) ATE297760T1 (enExample)
AU (1) AU2001230195A1 (enExample)
DE (1) DE60111503T2 (enExample)
ES (1) ES2241777T3 (enExample)
GB (1) GB0001315D0 (enExample)
PT (1) PT1259261E (enExample)
WO (1) WO2001052895A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
RU2214237C1 (ru) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Противогрибковое средство "брамизил"
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CA3063288A1 (en) 2017-05-12 2018-11-15 Mavalon Therapeutics Limited Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors
CN110200929A (zh) * 2018-12-14 2019-09-06 悦康药业集团上海制药有限公司 一种含有盐酸特比萘芬的口服片及其制备方法
CN109674757A (zh) * 2019-02-22 2019-04-26 济南康和医药科技有限公司 一种盐酸特比萘芬组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
US4894592A (en) * 1988-05-23 1990-01-16 Fusion Systems Corporation Electrodeless lamp energized by microwave energy
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
RU2184570C2 (ru) * 1997-09-30 2002-07-10 Дайити Фармасьютикал Ко., Лтд. Препараты для орального введения
JP2000086503A (ja) * 1998-09-07 2000-03-28 Pola Chem Ind Inc 錠剤医薬組成物

Also Published As

Publication number Publication date
US20030017200A1 (en) 2003-01-23
EP1259261A1 (en) 2002-11-27
JP2003520252A (ja) 2003-07-02
ES2241777T3 (es) 2005-11-01
DE60111503D1 (de) 2005-07-21
US20100197804A1 (en) 2010-08-05
DE60111503T2 (de) 2006-05-18
WO2001052895A1 (en) 2001-07-26
ATE297760T1 (de) 2005-07-15
AU2001230195A1 (en) 2001-07-31
EP1259261B1 (en) 2005-06-15
GB0001315D0 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
DOP2019000185A (es) Una formulación sólida de dosificación farmacéutica
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
ITTO20000779A0 (it) Composizioni farmaceutiche.
NO20100367L (no) Fast farmasoytisk doseringsform
PA8472901A1 (es) Formulaciones farmaceuticas
SE9802973D0 (sv) Immediate release tablet
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
AR034517A1 (es) Formulacion farmaceutica
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
PT1259261E (pt) Composicoes farmaceuticas que compreendem terbinafina
DE602004006860D1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
AR039232A1 (es) Una formulacion farmaceutica que comprende al menos un compuesto seleccionado del grupo formado por hipnoticos no barbituricos y no benzodiacepinicos, y melatonina
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
IT1318401B1 (it) Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono.
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
UY27170A1 (es) Formulación de medicamento que contiene un agente agonista muscarínico
TW200621304A (en) Pharmaceutical composition
EE200800014A (et) Ravimikoostis, mis on valmistatud p””rdtranskriptaasi inhibiitori ja meldooniumi baasil
AR034810A1 (es) Composicion farmaceutica para la administracion por via nasal de estradiol y de noretisterona
HUP0300682A2 (hu) Dalfopristin/kinupristin kombinációit cefpirommal együtt tartalmazó gyógyszerkészítmények
MY158344A (en) Oral drug delivery system